BP
Brent Pfeiffenberger
President and CEO

Brent Pfeiffenberger insider trades: Century Therapeutics (IPSC) stock buys and sales

President and CEO, Century Therapeutics Last trade Dec 12, 2025 21 Form 4 filings
$15K
Sold, last 12 months
1 sale
$48K
Bought, last 12 months
2 buys
8
Open-market trades
since 2025
3
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Brent reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 12, 2025IPSC↑ Buy$30K
Nov 19, 2025IPSC↑ Buy$17K
Nov 17, 2025IPSC↓ Sell$15K
Sep 8, 2025IPSC↓ Sell$244
Jun 9, 2025IPSC↓ Sell$295
May 16, 2025IPSC↓ Sell$16K
Mar 10, 2025IPSC↓ Sell$1K
Feb 18, 2025IPSC↓ Sell$27K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other IPSC insiders

Open-market trades in the last 12 months

About Brent Pfeiffenberger's insider trades

Brent Pfeiffenberger is President and CEO at Century Therapeutics (IPSC). Since Feb 18, 2025, Brent has reported 2 open-market purchases worth $48K and 6 sales worth $60K on SEC Form 4. In the last 12 months: 2 buys ($48K) and 1 sale ($15K).

Their filings also include shares withheld for taxes (7 filings), grants and awards (7 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IPSC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.